2014
Diagnostic and therapeutic potentials of exosomes in CNS diseases
Kawikova I, Askenase PW. Diagnostic and therapeutic potentials of exosomes in CNS diseases. Brain Research 2014, 1617: 63-71. PMID: 25304360, PMCID: PMC4862949, DOI: 10.1016/j.brainres.2014.09.070.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsBiomarkersBrainCell CommunicationCentral Nervous System DiseasesDrug CarriersExosomesHumansConceptsCell communication systemIntercellular communicationGenetic materialPhysiological functionsMicro RNAsExosomesNovel diagnostic biomarkersUnique siteIndividual exosomesTantalizing questionPathological processesGlial cellsRecognition of antigenCellsFundamental roleHippocampal neuronsCNS cellsTherapeutic potentialDiagnostic biomarkersDistant sitesPrecise targetingDiscoverySitesRNAExtracellular nanoparticles
2011
Risperidone-Related Improvement of Irritability in Children with Autism Is not Associated with Changes in Serum of Epidermal Growth Factor and Interleukin-13
Tobiasova Z, van der Lingen KH, Scahill L, Leckman JF, Zhang Y, Chae W, McCracken JT, McDougle CJ, Vitiello B, Tierney E, Aman MG, Arnold LE, Katsovich L, Hoekstra PJ, Volkmar F, Bothwell AL, Kawikova I. Risperidone-Related Improvement of Irritability in Children with Autism Is not Associated with Changes in Serum of Epidermal Growth Factor and Interleukin-13. Journal Of Child And Adolescent Psychopharmacology 2011, 21: 555-564. PMID: 22070180, PMCID: PMC3279715, DOI: 10.1089/cap.2010.0134.Peer-Reviewed Original ResearchConceptsMedication-free subjectsEpidermal growth factorHealthy controlsInflammatory markersIL-13IL-1 receptor antagonistGrowth factorSerum inflammatory markersChemoattractant protein-1Placebo groupClinical improvementBaseline visitIL-17Serum levelsCytokine concentrationsInflammatory moleculesSerum concentrationsClinical trialsHealthy subjectsIL-1Interleukin-13RisperidoneAltered levelsProtein 1Diagnosis of autism